Identifying patients at risk for augmented renal clearance in the ICU - limitations and challenges

Area of Science:

• Critical care medicine
• Pharmacokinetics
• Nephrology

Background:

• Augmented renal clearance (ARC) significantly impacts antibiotic exposure in critically ill patients.
• Accurate identification of patients with ARC is essential for optimizing drug therapy.
• Decreased antibiotic exposure due to ARC can lead to treatment failure.

Purpose of the Study:

• To highlight the importance of identifying patients at risk for augmented renal clearance.
• To discuss the characteristics of patients typically exhibiting ARC.
• To address the limitations of current markers and the ongoing search for suitable alternatives.

Main Methods:

• Review of existing evidence on augmented renal clearance in critically ill patients.
• Analysis of patient demographics and organ dysfunction severity associated with ARC.
• Discussion of potential physiological mechanisms and surrogate markers for ARC.

Main Results:

• Younger patients with low to moderate organ dysfunction are frequently identified as being at risk for ARC.
• This patient group often experiences decreased exposure to renally eliminated antibiotics.
• Established surrogate markers, like cardiac output, have not proven adequate for identifying ARC.

Conclusions:

• There is a continued need for reliable methods to identify patients with augmented renal clearance.
• Understanding patient profiles associated with ARC is key to preventing subtherapeutic antibiotic levels.
• Further research is required to validate novel surrogate markers for ARC.